HEADER VIRAL PROTEIN 04-AUG-23 8KBK TITLE STRUCTURE OF ACRIIA7 COMPLEXED WITH 1',2'-CADPR AND CGG COMPND MOL_ID: 1; COMPND 2 MOLECULE: INHIBITOR OF TYPE II CRISPR-CAS SYSTEM; COMPND 3 CHAIN: A, D, B, C; COMPND 4 SYNONYM: ACRIIA7; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: METAGENOME; SOURCE 3 ORGANISM_TAXID: 256318; SOURCE 4 GENE: ACRIIA7; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.XIAO,Y.FENG REVDAT 4 13-NOV-24 8KBK 1 JRNL REVDAT 3 06-NOV-24 8KBK 1 JRNL REVDAT 2 30-OCT-24 8KBK 1 REMARK REVDAT 1 07-AUG-24 8KBK 0 JRNL AUTH D.LI,Y.XIAO,I.FEDOROVA,W.XIONG,Y.WANG,X.LIU,E.HUITING,J.REN, JRNL AUTH 2 Z.GAO,X.ZHAO,X.CAO,Y.ZHANG,J.BONDY-DENOMY,Y.FENG JRNL TITL SINGLE PHAGE PROTEINS SEQUESTER SIGNALS FROM TIR AND JRNL TITL 2 CGAS-LIKE ENZYMES. JRNL REF NATURE 2024 JRNL REFN ESSN 1476-4687 JRNL PMID 39478223 JRNL DOI 10.1038/S41586-024-08122-4 REMARK 2 REMARK 2 RESOLUTION. 2.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.20.1_4487: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.08 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 21044 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 1080 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.0800 - 4.5500 0.98 2570 135 0.1940 0.2416 REMARK 3 2 4.5500 - 3.6200 0.99 2523 138 0.1927 0.2443 REMARK 3 3 3.6200 - 3.1600 0.98 2473 168 0.2384 0.3036 REMARK 3 4 3.1600 - 2.8700 0.98 2518 117 0.2790 0.3253 REMARK 3 5 2.8700 - 2.6700 0.98 2499 133 0.2919 0.4009 REMARK 3 6 2.6700 - 2.5100 0.97 2454 128 0.3017 0.3997 REMARK 3 7 2.5100 - 2.3800 0.97 2447 143 0.3189 0.3950 REMARK 3 8 2.3800 - 2.2800 0.97 2480 118 0.3298 0.3965 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 38.150 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 3600 REMARK 3 ANGLE : 2.056 4916 REMARK 3 CHIRALITY : 0.122 538 REMARK 3 PLANARITY : 0.013 582 REMARK 3 DIHEDRAL : 23.522 604 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8KBK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1300039776. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUL-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 S 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21073 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.280 REMARK 200 RESOLUTION RANGE LOW (A) : 47.760 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 1.21100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M POTASSIUM THIOCYANATE, 20% W/V REMARK 280 POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 52.13500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.84500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 52.13500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.84500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -68.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 103 REMARK 465 GLU B 103 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 310 O HOH C 207 2.03 REMARK 500 O HOH C 206 O HOH C 208 2.04 REMARK 500 NE1 TRP B 87 O18 MF6 B 201 2.05 REMARK 500 N PHE B 3 O HOH B 301 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU C 88 CA - CB - CG ANGL. DEV. = 18.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 59 -76.61 -112.98 REMARK 500 GLU C 64 -1.12 77.92 REMARK 500 REMARK 500 REMARK: NULL DBREF1 8KBK A 1 103 UNP A0A447EB45_9ZZZZ DBREF2 8KBK A A0A447EB45 1 103 DBREF1 8KBK D 1 103 UNP A0A447EB45_9ZZZZ DBREF2 8KBK D A0A447EB45 1 103 DBREF1 8KBK B 1 103 UNP A0A447EB45_9ZZZZ DBREF2 8KBK B A0A447EB45 1 103 DBREF1 8KBK C 1 103 UNP A0A447EB45_9ZZZZ DBREF2 8KBK C A0A447EB45 1 103 SEQADV 8KBK SER A 0 UNP A0A447EB4 EXPRESSION TAG SEQADV 8KBK SER D 0 UNP A0A447EB4 EXPRESSION TAG SEQADV 8KBK SER B 0 UNP A0A447EB4 EXPRESSION TAG SEQADV 8KBK SER C 0 UNP A0A447EB4 EXPRESSION TAG SEQRES 1 A 104 SER MSE THR PHE GLY GLN ALA LEU GLU SER LEU LYS ARG SEQRES 2 A 104 GLY HIS LEU VAL ALA ARG LYS GLY TRP ASN GLY LYS GLY SEQRES 3 A 104 MSE PHE ILE PHE MSE ARG PRO GLU ASP SER LEU PRO THR SEQRES 4 A 104 ASN MSE ILE VAL ASN GLN VAL LYS SER LEU PRO GLU SER SEQRES 5 A 104 PHE LYS ARG TRP VAL ALA ASN ASN HIS GLY ASP SER GLU SEQRES 6 A 104 THR ASP ARG ILE LYS PHE THR ALA TYR LEU CYS MSE LYS SEQRES 7 A 104 ALA ALA ASP GLY THR ILE VAL ASN GLY TRP LEU ALA SER SEQRES 8 A 104 GLN THR ASP MSE LEU ALA ASN ASP TRP VAL ILE VAL GLU SEQRES 1 D 104 SER MSE THR PHE GLY GLN ALA LEU GLU SER LEU LYS ARG SEQRES 2 D 104 GLY HIS LEU VAL ALA ARG LYS GLY TRP ASN GLY LYS GLY SEQRES 3 D 104 MSE PHE ILE PHE MSE ARG PRO GLU ASP SER LEU PRO THR SEQRES 4 D 104 ASN MSE ILE VAL ASN GLN VAL LYS SER LEU PRO GLU SER SEQRES 5 D 104 PHE LYS ARG TRP VAL ALA ASN ASN HIS GLY ASP SER GLU SEQRES 6 D 104 THR ASP ARG ILE LYS PHE THR ALA TYR LEU CYS MSE LYS SEQRES 7 D 104 ALA ALA ASP GLY THR ILE VAL ASN GLY TRP LEU ALA SER SEQRES 8 D 104 GLN THR ASP MSE LEU ALA ASN ASP TRP VAL ILE VAL GLU SEQRES 1 B 104 SER MSE THR PHE GLY GLN ALA LEU GLU SER LEU LYS ARG SEQRES 2 B 104 GLY HIS LEU VAL ALA ARG LYS GLY TRP ASN GLY LYS GLY SEQRES 3 B 104 MSE PHE ILE PHE MSE ARG PRO GLU ASP SER LEU PRO THR SEQRES 4 B 104 ASN MSE ILE VAL ASN GLN VAL LYS SER LEU PRO GLU SER SEQRES 5 B 104 PHE LYS ARG TRP VAL ALA ASN ASN HIS GLY ASP SER GLU SEQRES 6 B 104 THR ASP ARG ILE LYS PHE THR ALA TYR LEU CYS MSE LYS SEQRES 7 B 104 ALA ALA ASP GLY THR ILE VAL ASN GLY TRP LEU ALA SER SEQRES 8 B 104 GLN THR ASP MSE LEU ALA ASN ASP TRP VAL ILE VAL GLU SEQRES 1 C 104 SER MSE THR PHE GLY GLN ALA LEU GLU SER LEU LYS ARG SEQRES 2 C 104 GLY HIS LEU VAL ALA ARG LYS GLY TRP ASN GLY LYS GLY SEQRES 3 C 104 MSE PHE ILE PHE MSE ARG PRO GLU ASP SER LEU PRO THR SEQRES 4 C 104 ASN MSE ILE VAL ASN GLN VAL LYS SER LEU PRO GLU SER SEQRES 5 C 104 PHE LYS ARG TRP VAL ALA ASN ASN HIS GLY ASP SER GLU SEQRES 6 C 104 THR ASP ARG ILE LYS PHE THR ALA TYR LEU CYS MSE LYS SEQRES 7 C 104 ALA ALA ASP GLY THR ILE VAL ASN GLY TRP LEU ALA SER SEQRES 8 C 104 GLN THR ASP MSE LEU ALA ASN ASP TRP VAL ILE VAL GLU MODRES 8KBK MSE A 1 MET MODIFIED RESIDUE MODRES 8KBK MSE A 26 MET MODIFIED RESIDUE MODRES 8KBK MSE A 30 MET MODIFIED RESIDUE MODRES 8KBK MSE A 40 MET MODIFIED RESIDUE MODRES 8KBK MSE A 76 MET MODIFIED RESIDUE MODRES 8KBK MSE A 94 MET MODIFIED RESIDUE MODRES 8KBK MSE D 1 MET MODIFIED RESIDUE MODRES 8KBK MSE D 26 MET MODIFIED RESIDUE MODRES 8KBK MSE D 30 MET MODIFIED RESIDUE MODRES 8KBK MSE D 40 MET MODIFIED RESIDUE MODRES 8KBK MSE D 76 MET MODIFIED RESIDUE MODRES 8KBK MSE D 94 MET MODIFIED RESIDUE MODRES 8KBK MSE B 1 MET MODIFIED RESIDUE MODRES 8KBK MSE B 26 MET MODIFIED RESIDUE MODRES 8KBK MSE B 30 MET MODIFIED RESIDUE MODRES 8KBK MSE B 40 MET MODIFIED RESIDUE MODRES 8KBK MSE B 76 MET MODIFIED RESIDUE MODRES 8KBK MSE B 94 MET MODIFIED RESIDUE MODRES 8KBK MSE C 1 MET MODIFIED RESIDUE MODRES 8KBK MSE C 26 MET MODIFIED RESIDUE MODRES 8KBK MSE C 30 MET MODIFIED RESIDUE MODRES 8KBK MSE C 40 MET MODIFIED RESIDUE MODRES 8KBK MSE C 76 MET MODIFIED RESIDUE MODRES 8KBK MSE C 94 MET MODIFIED RESIDUE HET MSE A 1 8 HET MSE A 26 8 HET MSE A 30 8 HET MSE A 40 8 HET MSE A 76 8 HET MSE A 94 8 HET MSE D 1 8 HET MSE D 26 8 HET MSE D 30 8 HET MSE D 40 8 HET MSE D 76 8 HET MSE D 94 8 HET MSE B 1 8 HET MSE B 26 8 HET MSE B 30 8 HET MSE B 40 8 HET MSE B 76 8 HET MSE B 94 8 HET MSE C 1 8 HET MSE C 26 8 HET MSE C 30 8 HET MSE C 40 8 HET MSE C 76 8 HET MSE C 94 8 HET MF6 A 201 70 HET C2E D 301 46 HET MF6 B 201 70 HET C2E B 202 46 HETNAM MSE SELENOMETHIONINE HETNAM MF6 (1S,3R,4R,6R,9S,11R,14R,15S,16R,18R)-4-(6-AMINO-9H- HETNAM 2 MF6 PURIN-9-YL)-9,11,15,16,18-PENTAHYDROXY-2,5,8,10,12,17- HETNAM 3 MF6 HEXAOXA-9LAMBDA~5~,11LAMBDA~5~- HETNAM 4 MF6 DIPHOSPHATRICYCLO[12.2.1.1~3,6~]OCTADECANE-9,11-DIONE HETNAM C2E 9,9'-[(2R,3R,3AS,5S,7AR,9R,10R,10AS,12S,14AR)-3,5,10, HETNAM 2 C2E 12-TETRAHYDROXY-5,12-DIOXIDOOCTAHYDRO-2H,7H-DIFURO[3, HETNAM 3 C2E 2-D:3',2'-J][1,3,7,9,2, HETNAM 4 C2E 8]TETRAOXADIPHOSPHACYCLODODECINE-2,9-DIYL]BIS(2-AMINO- HETNAM 5 C2E 1,9-DIHYDRO-6H-PURIN-6-ONE) HETSYN MF6 1'-2' GCADPR HETSYN C2E C-DI-GMP; CYCLIC DIGUANOSINE MONOPHOSPHATE FORMUL 1 MSE 24(C5 H11 N O2 SE) FORMUL 5 MF6 2(C15 H21 N5 O13 P2) FORMUL 6 C2E 2(C20 H24 N10 O14 P2) FORMUL 9 HOH *31(H2 O) HELIX 1 AA1 THR A 2 ARG A 12 1 11 HELIX 2 AA2 THR A 38 VAL A 45 1 8 HELIX 3 AA3 PRO A 49 HIS A 60 1 12 HELIX 4 AA4 SER A 90 ALA A 96 1 7 HELIX 5 AA5 THR D 2 ARG D 12 1 11 HELIX 6 AA6 THR D 38 GLN D 44 1 7 HELIX 7 AA7 PRO D 49 GLY D 61 1 13 HELIX 8 AA8 SER D 90 ALA D 96 1 7 HELIX 9 AA9 THR B 2 ARG B 12 1 11 HELIX 10 AB1 THR B 38 GLN B 44 1 7 HELIX 11 AB2 PRO B 49 HIS B 60 1 12 HELIX 12 AB3 SER B 90 ALA B 96 1 7 HELIX 13 AB4 THR C 2 ARG C 12 1 11 HELIX 14 AB5 THR C 38 VAL C 45 1 8 HELIX 15 AB6 PRO C 49 HIS C 60 1 12 HELIX 16 AB7 SER C 90 ALA C 96 1 7 SHEET 1 AA1 2 VAL A 16 ARG A 18 0 SHEET 2 AA1 2 TRP A 99 ILE A 101 -1 O VAL A 100 N ALA A 17 SHEET 1 AA2 3 PHE A 27 ARG A 31 0 SHEET 2 AA2 3 TYR A 73 LYS A 77 -1 O TYR A 73 N ARG A 31 SHEET 3 AA2 3 ILE A 83 ASN A 85 -1 O VAL A 84 N MSE A 76 SHEET 1 AA3 2 ASP A 34 PRO A 37 0 SHEET 2 AA3 2 ARG A 67 PHE A 70 -1 O PHE A 70 N ASP A 34 SHEET 1 AA4 2 LEU D 15 ARG D 18 0 SHEET 2 AA4 2 TRP D 99 GLU D 103 -1 O VAL D 102 N LEU D 15 SHEET 1 AA5 3 PHE D 27 ARG D 31 0 SHEET 2 AA5 3 TYR D 73 LYS D 77 -1 O TYR D 73 N ARG D 31 SHEET 3 AA5 3 ILE D 83 ASN D 85 -1 O VAL D 84 N MSE D 76 SHEET 1 AA6 2 ASP D 34 PRO D 37 0 SHEET 2 AA6 2 ARG D 67 PHE D 70 -1 O PHE D 70 N ASP D 34 SHEET 1 AA7 2 VAL B 16 ARG B 18 0 SHEET 2 AA7 2 TRP B 99 ILE B 101 -1 O VAL B 100 N ALA B 17 SHEET 1 AA8 3 PHE B 27 ARG B 31 0 SHEET 2 AA8 3 TYR B 73 LYS B 77 -1 O TYR B 73 N ARG B 31 SHEET 3 AA8 3 ILE B 83 ASN B 85 -1 O VAL B 84 N MSE B 76 SHEET 1 AA9 2 ASP B 34 PRO B 37 0 SHEET 2 AA9 2 ARG B 67 PHE B 70 -1 O PHE B 70 N ASP B 34 SHEET 1 AB1 2 LEU C 15 ARG C 18 0 SHEET 2 AB1 2 TRP C 99 VAL C 102 -1 O VAL C 100 N ALA C 17 SHEET 1 AB2 3 PHE C 27 ARG C 31 0 SHEET 2 AB2 3 TYR C 73 LYS C 77 -1 O TYR C 73 N ARG C 31 SHEET 3 AB2 3 ILE C 83 ASN C 85 -1 O VAL C 84 N MSE C 76 SHEET 1 AB3 2 ASP C 34 PRO C 37 0 SHEET 2 AB3 2 ARG C 67 PHE C 70 -1 O ILE C 68 N LEU C 36 LINK C SER A 0 N MSE A 1 1555 1555 1.34 LINK C MSE A 1 N THR A 2 1555 1555 1.32 LINK C GLY A 25 N MSE A 26 1555 1555 1.33 LINK C MSE A 26 N PHE A 27 1555 1555 1.33 LINK C PHE A 29 N MSE A 30 1555 1555 1.33 LINK C MSE A 30 N ARG A 31 1555 1555 1.30 LINK C ASN A 39 N MSE A 40 1555 1555 1.33 LINK C MSE A 40 N ILE A 41 1555 1555 1.33 LINK C CYS A 75 N MSE A 76 1555 1555 1.32 LINK C MSE A 76 N LYS A 77 1555 1555 1.32 LINK C ASP A 93 N MSE A 94 1555 1555 1.33 LINK C MSE A 94 N LEU A 95 1555 1555 1.33 LINK C SER D 0 N MSE D 1 1555 1555 1.35 LINK C MSE D 1 N THR D 2 1555 1555 1.34 LINK C GLY D 25 N MSE D 26 1555 1555 1.32 LINK C MSE D 26 N PHE D 27 1555 1555 1.33 LINK C PHE D 29 N MSE D 30 1555 1555 1.33 LINK C MSE D 30 N ARG D 31 1555 1555 1.28 LINK C ASN D 39 N MSE D 40 1555 1555 1.32 LINK C MSE D 40 N ILE D 41 1555 1555 1.32 LINK C CYS D 75 N MSE D 76 1555 1555 1.32 LINK C MSE D 76 N LYS D 77 1555 1555 1.32 LINK C ASP D 93 N MSE D 94 1555 1555 1.33 LINK C MSE D 94 N LEU D 95 1555 1555 1.34 LINK C SER B 0 N MSE B 1 1555 1555 1.34 LINK C MSE B 1 N THR B 2 1555 1555 1.33 LINK C GLY B 25 N MSE B 26 1555 1555 1.32 LINK C MSE B 26 N PHE B 27 1555 1555 1.33 LINK C PHE B 29 N MSE B 30 1555 1555 1.33 LINK C MSE B 30 N ARG B 31 1555 1555 1.30 LINK C ASN B 39 N MSE B 40 1555 1555 1.32 LINK C MSE B 40 N ILE B 41 1555 1555 1.33 LINK C CYS B 75 N MSE B 76 1555 1555 1.34 LINK C MSE B 76 N LYS B 77 1555 1555 1.33 LINK C ASP B 93 N MSE B 94 1555 1555 1.33 LINK C MSE B 94 N LEU B 95 1555 1555 1.33 LINK C SER C 0 N MSE C 1 1555 1555 1.33 LINK C MSE C 1 N THR C 2 1555 1555 1.32 LINK C GLY C 25 N MSE C 26 1555 1555 1.33 LINK C MSE C 26 N PHE C 27 1555 1555 1.33 LINK C PHE C 29 N MSE C 30 1555 1555 1.32 LINK C MSE C 30 N ARG C 31 1555 1555 1.30 LINK C ASN C 39 N MSE C 40 1555 1555 1.32 LINK C MSE C 40 N ILE C 41 1555 1555 1.32 LINK C CYS C 75 N MSE C 76 1555 1555 1.33 LINK C MSE C 76 N LYS C 77 1555 1555 1.33 LINK C ASP C 93 N MSE C 94 1555 1555 1.32 LINK C MSE C 94 N LEU C 95 1555 1555 1.33 CRYST1 104.270 57.690 92.510 90.00 121.71 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009590 0.000000 0.005926 0.00000 SCALE2 0.000000 0.017334 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012706 0.00000